Kitov Pharma Ltd
NASDAQ:KTOV (12/21/2020, 7:00:01 PM)
After market: 4.11 -0.06 (-1.44%)4.17
+0.09 (+2.21%)
Kitov Pharmaceuticals Holdings Ltd. is a pharmaceutical company which focused on the development of therapeutic candidates. The company's product candidate consists of KIT-302, is formulated for treatment of pain caused by osteoarthritis and hypertension, which can be pre-existing or caused by the treatment for OA. Kitov Pharmaceuticals Holdings Ltd. is based in Jerusalem, Israel.
Kitov Pharma Ltd
ONE AZRIELI CENTER ROUND TOWER 132 MENACHEM BEGIN ROAD
TEL AVIV L3 6701101
P: 972-3933-3121
CEO: Isaac Israel
The new cohort will explore the combination of CM24, Opdivo (“nivolumab”) and Abraxane (“albumin-bound paclitaxel; nab-paclitaxel”) in patients with pancreatic cancer
Here you can normally see the latest stock twits on KTOV, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: